The University of Chicago Medicine Comer Children's Hospital is the first medical center in Illinois to offer I131-MIBG therapy. I131-MIBG therapy is one step in a complex treatment plan for children with relapsed or difficult-to-treat neuroblastoma and is also being tested in newly diagnosed high-risk neuroblastoma patients.

Parents play an important role in caring for children receiving this unique therapy. We've prepared this information to help answer some of the questions you may have about the treatment.

What To Know About MIBG Therapy